home / stock / xrtx / xrtx quote
Last: | $2.677 |
---|---|
Change Percent: | 1.8% |
Open: | $2.552 |
Close: | $2.677 |
High: | $2.8472 |
Low: | $2.55 |
Volume: | 3,591 |
Last Trade Date Time: | 05/03/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.677 | $2.552 | $2.677 | $2.8472 | $2.55 | 3,591 | 05-03-2024 |
$2.5987 | $2.52 | $2.5987 | $2.7 | $2.52 | 4,294 | 05-02-2024 |
$2.5615 | $2.6261 | $2.5615 | $2.65 | $2.535 | 2,592 | 05-01-2024 |
$2.55 | $2.698 | $2.55 | $2.75 | $2.55 | 10,521 | 04-30-2024 |
$2.645 | $3.12 | $2.645 | $3.24 | $2.56 | 48,519 | 04-29-2024 |
$2.93 | $2.75 | $2.93 | $3 | $2.5301 | 25,186 | 04-26-2024 |
$2.59 | $2.79 | $2.59 | $2.84 | $2.5101 | 26,337 | 04-25-2024 |
$2.9018 | $2.96 | $2.9018 | $2.9999 | $2.8462 | 10,960 | 04-24-2024 |
$2.94 | $2.7001 | $2.94 | $2.9437 | $2.7001 | 8,303 | 04-23-2024 |
$3 | $2.82 | $3 | $3 | $2.82 | 23,414 | 04-22-2024 |
$2.9972 | $2.955 | $2.9972 | $3 | $2.9 | 13,020 | 04-19-2024 |
$3.0501 | $3.16 | $3.0501 | $3.16 | $2.83 | 30,676 | 04-18-2024 |
$3.17 | $3.03 | $3.17 | $3.23 | $3 | 4,048 | 04-17-2024 |
$3.1 | $3.1 | $3.1 | $3.1799 | $3.0601 | 8,604 | 04-16-2024 |
$3.22 | $3.37 | $3.22 | $3.5499 | $3.11 | 7,909 | 04-15-2024 |
$3.36 | $3.56 | $3.36 | $3.56 | $3.36 | 11,737 | 04-12-2024 |
$3.555 | $3.6465 | $3.555 | $3.67 | $3.5201 | 11,266 | 04-11-2024 |
$3.5135 | $3.65 | $3.5135 | $3.84 | $3.5001 | 14,127 | 04-10-2024 |
$3.81 | $3.92 | $3.81 | $3.92 | $3.7 | 11,610 | 04-09-2024 |
$3.9046 | $3.72 | $3.9046 | $3.92 | $3.38 | 21,360 | 04-08-2024 |
News, Short Squeeze, Breakout and More Instantly...
XORTX Therapeutics Inc. Company Name:
XRTX Stock Symbol:
NASDAQ Market:
CALGARY, Alberta, April 22, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA WKN: A3UNZ), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney d...
Malibu, CA, United States (ABN Newswire) - In this segment of Money Talk Radio with Ellis Martin, we speak with Dr. Allen Davidoff, CEO of XORTX Therapeutics (NASDAQ:XRTX) (CVE:XRTX), a pioneer in developing new therapies for progressive kidney disease and diabetes. Recently Vertex Pharmaceut...
CALGARY, Alberta, April 08, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfu...